CA2192520A1 — Expandable stent and method for delivery of same
Assigned to Evysio Medical Devices ULC · Expires 1997-09-05 · 29y expired
What this patent protects
An expandable stent comprising a proximal end and a distal end in communication with one another. A tubular wall is disposed between the proximal end and the distal end. The tubular wall having a longitudinal axis and a poroussurface defined by a plurality intersecting members ar…
USPTO Abstract
An expandable stent comprising a proximal end and a distal end in communication with one another. A tubular wall is disposed between the proximal end and the distal end. The tubular wall having a longitudinal axis and a poroussurface defined by a plurality intersecting members arranged to define a first repeating pattern comprised of a polygon. The polygon has a pair of side walls substantially parallel to the longitudinal axis, a concave-shaped first wall having a first apex and a convex-shaped second wall having a second apex, the first wall and the second wall connecting the side walls. At least one of the first apex and the second apex is substantially flat. The stent is expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force on the stent. A bifurcated stent including the first repeating pattern is also described.
Drugs covered by this patent
- Elocon (MOMETASONE FUROATE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.